Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00618553|
Recruitment Status : Active, not recruiting
First Posted : February 20, 2008
Last Update Posted : August 4, 2017
|Condition or disease||Intervention/treatment||Phase|
|Lung Cancer||Other: Questionnaire Behavioral: Pulmonary Rehabilitation||Phase 2|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||75 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Efficacy of Pulmonary Rehabilitation in Improving Surgical Eligibility for Lung Resection|
|Actual Study Start Date :||January 2008|
|Estimated Primary Completion Date :||January 2019|
|Estimated Study Completion Date :||January 2019|
Experimental: Pulmonary Rehabilitation
Pulmonary Rehabilitation - Rehabilitation treatment given over about 3-4 weeks. Questionnaire regarding quality-of-life that lasts about 30 minutes.
Questionnaire regarding quality-of-life that lasts about 30 minutes.
Other Name: SurveyBehavioral: Pulmonary Rehabilitation
Rehabilitation treatment given over about 3-4 weeks.
- Treatment Success (conversion from ineligible to eligible status for lung resection following Pulmonary rehabilitation (PR)) [ Time Frame: Baseline and post treatment (following 3-4 weeks of PR) ]
- Examine health of pulmonary rehabilitation participants after surgery. [ Time Frame: 2 Years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00618553
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Vickie Shannon, MD, BS||M.D. Anderson Cancer Center|